drugset / Trial / NCT02378441
Phase 1 Study to Compare the Safety, Pharmacokinetic Profiles of CJ-30056 and Lipitor 20mg/Glucophage SR 750mg
RandomizedCrossoverOpen-labelTreatment
Summary
This study is designed to evaluate safety and pharmacokinetic properties of the two treatments, the administration of CJ-30056 and the co-administration of atorvastatin 20mg and metformin SR 750mg, in healthy volunteers.
Timeline
- Start
- 2015-02
- Primary completion
- 2015-03
- Completion
- 2015-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atorvastatin | Small molecule | 20 mg | — |
| Subject | CJ-30056 | Unknown | — | — |
| Subject | Metformin | Small molecule | 750 mg | — |
Indications
No indication recorded.